The Damage of Vaccine Misinformation
From 2013 to 2016, negative information about the HPV (human papillomavirus) vaccine spread widely through Danish media outlets. As a result, thousands of girls did not receive the vaccine.
Conditions: HIV Infections; HPV Infection Intervention: Biological: Human Papillomavirus 9-valent Vaccine, Recombinant Sponsors: University Hospital Virgen de las Nieves; Instituto de Salud Carlos III Recruiting
Conditions: HPV Positive Oropharyngeal Squamous Cell Carcinoma; HIV-1-infection; HPV Infection Interventions: Biological: 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58); Other: Saline Placebo Sponsors: Weill Medical College of Cornell University; H. Lee Moffitt Cancer Center and Research Institute; University of Sao Paulo; University of Puerto Rico; Mexican National Institute of Public Health; National Cancer In...
ConclusionsDifferences were observed in declines in the proportion of human papillomavirus 16/18 lesions by area-based measures since the introduction of human papillomavirus vaccines, with greater and earlier declines in areas with fewer residents living in poverty and racial minorities. Ongoing human papillomavirus vaccine impact monitoring is necessary to track differences by sociodemographic characteristics.
With more than 28 million doses administered since 2014, the CDC hasn ’t identified any new or unexpected safety concerns with the human papillomavirus vaccine, according to a pair of CDC studies published in Pediatrics.
The objective of the meeting was to assess what is known beyond reasonable doubt and conversely what areas need additional studies. Although the meeting could not cover all aspects of vaccine safety science, many of the most important issues were addressed by a group of about 30 experts to determine what is already known and what additional studies are merited to assess the safety of the vaccines currently in use. The meeting began with reviews of the current situation in different parts of the world, followed by reviews of specific controversial areas, including the incidence of certain conditions after vaccination and th...
Abstract We conducted a critical appraisal of published Phase 2 and 3 efficacy trials in relation to the prevention of cervical cancer in women. Our analysis shows the trials themselves generated significant uncertainties undermining claims of efficacy in these data. There were 12 randomised control trials (RCTs) of Cervarix and Gardasil. The trial populations did not reflect vaccination target groups due to differences in age and restrictive trial inclusion criteria. The use of composite and distant surrogate outcomes makes it impossible to determine effects on clinically significant outcomes. It is still uncerta...
The aim of the study was to examine adolescents' influence on human papillomavirus (HPV) vaccine decision-making and receipt during clinical visits.